Clinical Study of Impact of Different Pacing Site in Patients
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jun 14, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different locations in the heart can be used for pacing in patients with bradyarrhythmias (slow heart rhythms) and heart failure. Pacing helps improve heart function and can increase the chances of survival for these patients. The trial aims to compare the effectiveness and safety of various pacing sites, such as different areas in the heart's upper and lower chambers, to see which is best for patients in both the short and long term.
To be eligible for this study, participants must have received a pacemaker at the Second Hospital of Zhejiang Medical University and be able to understand and cooperate with the study team. If you join the trial, you can expect regular monitoring and assessments to ensure your safety and to gather valuable information about the different pacing sites. This study is important because it could help improve treatment options for patients with heart conditions, making it a significant step forward in cardiac care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons.
- • Patients who have the ability to understand the test and can cooperate with investigators.
- Exclusion Criteria:
- • Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors.
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials